SINGAPORE (Nikkei Markets) -- Singapore's healthcare players are shifting strategy as rising costs and growing competition erode the city-state's appeal as a destination for medical tourism.
Companies like IHH Healthcare Bhd and Raffles Medical Group are expanding overseas at a robust pace, leveraging on the brand names they've already established to draw increasingly affluent patients in populous countries such as China and India.
